Synbiotic diet produces antidepressant-like effects but alters ketamine activity in an avian model of treatment-resistant depression
Stephen W. White, Tara D. Clover, Kenneth J. Sufka
Behavioural Pharmacology August 21, 2025 DOI: 10.1097/fbp.0000000000000850 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Socially raised Black Australorp chicks |
| Interventions | synbiotic diet ketamine |
| Dose | 0, 5, or 10 mg/kg/ml ketamine |
| Duration | 7-day feed intervention, 90-min isolation stressor |
| Topics | Depression Esketamine Ketamine |
| Key findings | A synbiotic diet produced antidepressant-like effects in an avian model, but combined with ketamine it suppressed distress vocalizations, suggesting a negative interaction. |
Abstract
Pre- and probiotics promote a diverse and functional gut microbiota and have demonstrated both anxiolytic and antidepressant effects; however, how synbiotic diet interacts with antidepressant medications has not been fully investigated. This study sought to evaluate the potential anxiolytic or antidepressant effects of a synbiotic diet in an avian model that presents homologies with treatment-resistant depression. In addition, we sought to evaluate the potential interaction of a synbiotic diet combined with select doses of ketamine. Socially raised Black Australorp chicks were given either standard or synbiotic feed for 7 days. At 7 days posthatch, chicks from each feed condition were administered either 0, 5, or 10 mg/kg/ml ketamine 15 min before a 90-min isolation stressor, which elicits distress vocalizations (DVocs) that temporally represent a panic-like phase followed by a depression-like phase. Saline-treated chicks given the synbiotic diet displayed significantly higher DVoc rates in the depression-like phase compared with saline-treated animals in the standard feed condition, indicative of attenuation of behavioral despair [F(1,22) = 5.45, P < 0.05]. Similarly, in the standard diet condition, ketamine 10 mg/kg produced elevated DVoc rates; however, under the synbiotic diet, both doses of ketamine produced a suppression of DVoc rates in the depression-like phase. These findings suggest that a synbiotic diet produces antidepressant-like effects in the model and a possible negative interaction between synbiotics and ketamine. While preliminary, the findings suggest the concurrent use of pre- and probiotic supplements and ketamine may produce contradictory effects and warrant further investigation.
Comparable studies
Other randomized controlled trials on ketamine for depression, most cited first.
Citations in the library
Cites 4
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets Science October 4, 2012
- Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence. Psychiatry Research 2022
- The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug. Pharmacological Reports October 2018
- Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry February 15, 2008